ABSTRACT
Rotor-stator axial clearance is a crucial design parameter affecting rotating machines' efficiency and safety. To accurately measure the dynamic axial clearance in high-speed machinery, a precise method based on time division multiplexing with frequency domain interferometry has been proposed. This method has proven robust and accurate through simulations and experiments. The inclusion of an optical switch enables the utilization of dispersive interferometry(DPI) and time division multiplexing for multiple channels of the light source. It achieves a static accuracy of 1.5â µm for a 15 mm range and a dynamic accuracy of 9â µm at 3000â rpm.
ABSTRACT
PURPOSE: The exact phenoconversion time from isolated rapid eye movement (REM) sleep behavior disorder (iRBD) to synucleinopathies remains unpredictable. This study investigated whole-brain dopaminergic damage pattern (DDP) with disease progression and predicted phenoconversion time in individual patients. METHODS: Age-matched 33 iRBD patients and 20 healthy controls with 11C-CFT-PET scans were enrolled. The patients were followed up 2-10 (6.7 ± 2.0) years. The phenoconversion year was defined as the base year, and every 2 years before conversion was defined as a stage. Support vector machine with leave-one-out cross-validation strategy was used to perform prediction. RESULTS: Dopaminergic degeneration of iRBD was found to occur about 6 years before conversion and then abnormal brain regions gradually expanded. Using DDP, area under curve (AUC) was 0.879 (90% sensitivity and 88.3% specificity) for predicting conversion in 0-2 years, 0.807 (72.7% sensitivity and 83.3% specificity) in 2-4 years, 0.940 (100% sensitivity and 84.6% specificity) in 4-6 years, and 0.879 (100% sensitivity and 80.7% specificity) over 6 years. In individual patients, predicted stages correlated with whole-brain dopaminergic levels (r = - 0.740, p < 0.001). CONCLUSION: Our findings suggest that DDP could accurately predict phenoconversion time of individual iRBD patients, which may help to screen patients for early intervention.
Subject(s)
REM Sleep Behavior Disorder , Humans , REM Sleep Behavior Disorder/diagnostic imaging , Brain/diagnostic imaging , Dopamine , Disease ProgressionABSTRACT
BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) is a highly malignant solid tumor that lacks early diagnostic methods. Recently, targeted immunotherapy and radiotherapy have been integrated with radionuclide-antibody conjugate drugs, which can be used for targeted diagnosis and dynamic imaging of tumors. CEACAM6 is overexpressed in pancreatic tumors and is a potential theranostic target for PDAC. We aimed to develop a novel targeted carrier for theranostics of PDAC and other solid tumors. METHODS: Based on camelid heavy-chain-only antibodies, we developed a CEACAM6-targeting recombinant antibody NY004, and evaluated it as a novel antibody-carrier for imaging and therapy of cancer in tumor models. We labeled NY004 with theranostic nuclides and applied this self-developed antibody platform in diagnostic imaging and antitumor assessment in PDAC models. RESULTS: Through microPET, IHC, and biodistribution assays, targeting and biodistribution of [89Zr]-NY004 in solid tumors including PDAC was examined, and the investigated tumors were all CEACAM6-positive malignancies. We found that NY004 was suitable for use as a drug carrier for radioimmunotheranostics. Our study showed that NY004 was characterized by high targeted uptake and a long retention time in PANC-1 tumors (up to 6 days post-injection), with good specificity and high imaging efficiency. Therapeutic evaluation of the radionuclide-labeled antibody drug [177Lu]-NY004 in PDAC tumor-bearing model revealed that NY004 had high and prolonged uptake in tumors, relatively low non-target organ uptake, and good anti-tumor efficacy. CONCLUSION: As a drug platform for radiotheranostics, CEACAM6-specific antibody NY004 met the requirements of easy-labeling, targeting specificity, and effective persistence in pancreatic adenocarcinoma tissues. KEY POINTS: ⢠[89Zr]-NY004 has good specificity and high imaging efficiency, and is characterized by high tumor-targeting uptake and a long tumor retention time as a PET molecular imaging tracer. ⢠Therapeutic radionuclide-conjugated antibody drug [177Lu]-NY004 has high uptake and prolonged uptake duration in tumors, low non-target organ uptake, and significant tumor-inhibiting efficacy in PDAC model. ⢠The self-developed antibody structure NY004 is a promising drug platform for radioimmunotheranostics of CEACAM6-positive tumors including pancreatic ductal adenocarcinoma.
Subject(s)
Adenocarcinoma , Carcinoma, Pancreatic Ductal , Pancreatic Neoplasms , Humans , Pancreatic Neoplasms/diagnostic imaging , Pancreatic Neoplasms/therapy , Pancreatic Neoplasms/pathology , Adenocarcinoma/pathology , Tissue Distribution , Carcinoma, Pancreatic Ductal/diagnostic imaging , Carcinoma, Pancreatic Ductal/therapy , Positron-Emission Tomography/methods , Radioisotopes/therapeutic use , Cell Line, Tumor , Pancreatic NeoplasmsABSTRACT
INTRODUCTION: The low sensitivity of [18F]-fluorodeoxyglucose ([18F]-FDG) for the diagnosis of gastric cancer limits its application. In this study, we aimed to investigate the potential advantage of [68 Ga]Ga-FAPI-04 over [18F]-FDG in the evaluation of gastric cancer. METHODS: This was a bicentric retrospective analysis of a prospective parent study (clinical trial: HS-KY-2020-826 (Huashan Hospital) and DF-2020-102 (Shanghai East Hospital)). Thirty-eight patients with gastric cancer (31 with adenocarcinoma and 7 with signet ring cell carcinoma) were included in this study. All of the participants underwent [68 Ga]Ga-FAPI-04 and [18F]-FDG imaging by positron emission tomography (PET)/computed tomography (CT) or PET/magnetic resonance (MR). The scans were interpreted by two experienced nuclear medicine physicians, and the maximum standardized uptake value (SUVmax) was calculated. Histopathological findings obtained from biopsy or resected surgical specimens were used as a reference for the final diagnosis. RESULTS: For the detection of primary gastric cancer, the sensitivities of [68 Ga]Ga-FAPI-04 PET and [18F]-FDG PET were 100% (38/38) and 82% (31/38), respectively (P = 0.016). Four cases of adenocarcinoma and three cases of signet ring cell carcinoma were missed by [18F]-FDG PET. The mean SUVmax of [68 Ga]Ga-FAPI-04 in tumours greater than 4 cm (11.0 ± 4.5) was higher than that in tumours less than 4 cm (4.5 ± 3.2) (P = 0.0015). The mean SUVmax of [68 Ga]Ga-FAPI-04 was higher in T2-4 tumours (9.7 ± 4.4) than in T1 tumours (3.1 ± 1.5) (P = 0.0002). For the detection of metastatic lesions, the sensitivities of [68 Ga]Ga-FAPI-04 PET and [18F]-FDG PET in 10 patients with regional lymph node metastasis and distant metastasis were 6/10 and 5/10, respectively. CONCLUSION: In this selected cohort, [68 Ga]Ga-FAPI-04 PET had a superior detection rate than [18F]-FDG PET for primary gastric cancer. [68 Ga]Ga-FAPI-04 PET could provide better performance with regard to gastric cancer diagnosis and staging. Prospective clinical trials are warranted.
Subject(s)
Fluorodeoxyglucose F18 , Stomach Neoplasms , China , Gallium Radioisotopes , Humans , Positron Emission Tomography Computed Tomography , Prospective Studies , Quinolines , Retrospective Studies , Stomach Neoplasms/diagnostic imagingABSTRACT
Sugars are essential regulatory molecules involved in plant growth and development and defense response. Although the relationship between sugars and disease resistance has been widely discussed, the underlying molecular mechanisms remain unexplored. Ring rot caused by Botryosphaeria dothidea (B. dothidea), which severely affects fruit quality and yield, is a destructive disease of apples (Malus domestica Borkh.). The present study found that the degree of disease resistance in apple fruit was closely related to glucose content. Therefore, the gene encoding a hexokinase, MdHXK1, was isolated from the apple cultivar 'Gala', and characterized during the defense response. Overexpression of MdHXK1 enhanced disease resistance in apple calli, leaves and fruits by increasing the expression levels of genes related to salicylate (SA) synthesis (PHYTOALEXIN DEFICIENT 4, PAD4; PHENYLALANINE AMMONIA-LYASE, PAL; and ENHANCED DISEASE SUSCEPTIBILITY 1, EDS1) and signaling (PR1; PR5; and NONEXPRESSER OF PR GENES 1, NPR1) as well as increasing the superoxide (O2- ) production rate and the hydrogen peroxide (H2 O2 ) content. Overall, the study provides new insights into the MdHXK1-mediated molecular mechanisms by which glucose signaling regulates apple ring rot resistance.
Subject(s)
Ascomycota , Malus , Ascomycota/physiology , Disease Resistance/genetics , Glucose/metabolism , Malus/genetics , Malus/metabolism , Plant Diseases/geneticsABSTRACT
Alzheimer's is the most common cause of dementia in the elderly. In this disease, genetic and environmental factors are involved. In Alzheimer's, changes of nucleotide 196 (G> A) or valine polymorphism of 66-methionine in the BDNF gene is a risk factor for brain-derived neurogenic factors. In China, this polymorphism has not been studied in Alzheimer's patients and perhaps this study could provide appropriate information on the prognosis and susceptibility of the disease. Therefore, in this case-control study, 73 patients with Alzheimer's disease and 100 patients as a healthy control group were studied. Blood samples were taken from the mentioned individuals and DNA was extracted. After quantitative and qualitative DNA analysis, a PCR-RFLP test was performed and the results of both groups were compared. The results showed that 14 patients and 7 people in the control group had BDNF gene polymorphism. In the patient group, the number of people with normal allele was 59. Heterozygous people were 8 and people with methionine/methionine alleles were 6. In the control group, 93 normal individuals, 5 heterozygous individuals, and 2 people had methionine/methionine alleles. In general, increasing the accumulation of valine/methionine polymorphism of the BDNF gene in Alzheimer's patients compared to control can indicate the role of this polymorphism. Clinically, patients with this polymorphism had a more unfavorable clinical condition compared to patients without it. Therefore, evaluation of the presence of this polymorphism can provide appropriate information about the disease status.
Subject(s)
Alzheimer Disease , Brain-Derived Neurotrophic Factor , Aged , Alzheimer Disease/genetics , Asian People/genetics , Brain-Derived Neurotrophic Factor/genetics , Case-Control Studies , Genotype , Humans , Methionine/genetics , Polymorphism, Genetic , Polymorphism, Single Nucleotide/genetics , Valine/geneticsABSTRACT
Frequency scanning interferometry using state-of-the-art high-speed frequency-swept laser source can be utilized to measure absolute distance on the order of micrometers to centimeters. Current distance demodulation methods based on fast Fourier transform (FFT) or fringe counting cannot achieve satisfactory accuracy when the number of sampling points within a frequency-sweeping period is small; the conventional Hilbert transform is more accurate, but it needs arctangent calculation and phase unwrapping, which is time consuming. So we propose a fast algorithm based on the conventional Hilbert transform to recover the distance from the interference signal. The algorithm is implemented by first performing a Hilbert transform and then solving the phase and the distance from the Hilbert signal with a novel, to the best of our knowledge, method that eliminates the need for arctangent calculation and phase unwrapping. The whole process took only 40 µs, and it is almost 2 times faster than the conventional Hilbert algorithm with little accuracy lost. Simulation results demonstrate that the proposed algorithm is more accurate than the FFT algorithm, and it achieved a standard deviation of 0.062 µm, which was less than that of the FFT, in our experiment at a distance of approximately 16 mm and measurement speed of 1 kHz.
ABSTRACT
Fusarium oxysporum f. sp. radicis-lycopersici (Forl) is a destructive soil-borne phytopathogenic fungus that causes Fusarium crown and root rot (FCRR) of tomato, leading to considerable field yield losses. In this study, we explored the antifungal capability of linalool, a natural plant volatile organic component, against Forl and its role in controlling FCRR symptoms in tomatoes. Our results showed that Forl mycelial growth was inhibited by the linalool treatment and that the linalool treatment damaged cell membrane integrity, enhanced reactive oxygen species levels, depleted glutathione, and reduced the activities of many antioxidant enzymes in Forl. Transcriptomic and proteomic analyses demonstrated that linalool also downregulated metabolic biosynthetic pathways at the transcript and protein levels, including redox, transporter activity, and carbohydrate metabolism in Forl. Moreover, linalool significantly decreased the expression of many Forl pathogenic genes, such as cell wall degrading enzymes (CWDEs) and G proteins, which is likely how a Forl infection was prevented. Importantly, exogenously applied linalool activated the salicylic acid (SA) and jasmonic acid (JA) defensive pathways to improve disease resistance and relieved the negative effects of Forl on plant growth. Taken together, we report that linalool is an effective fungicide against Forl and will be a promising green chemical agent for controlling FCRR.
Subject(s)
Fusarium , Solanum lycopersicum , Antifungal Agents/pharmacology , Proteomics , Plant Diseases/microbiologyABSTRACT
The oncogene c-Myc is aberrantly expressed and plays a key role in malignant transformation and progression of hepatocellular carcinoma (HCC). Here, we report that c-Myc is significantly up-regulated by tumor necrosis factor receptor-associated factor 6 (TRAF6), an E3 ubiquitin ligase, in hepatocarcinogenesis. High TRAF6 expression in clinical HCC samples correlates with poor prognosis, and the loss of one copy of the Traf6 gene in Traf6+/- mice significantly impairs liver tumorigenesis. Mechanistically, TRAF6 first interacts with and ubiquitinates histone deacetylase 3 (HDAC3) with K63-linked ubiquitin chains, which leads to the dissociation of HDAC3 from the c-Myc promoter and subsequent acetylation of histone H3 at K9, thereby epigenetically enhancing the mRNA expression of c-Myc. Second, the K63-linked ubiquitination of HDAC3 impairs the HDAC3 interaction with c-Myc and promotes c-Myc protein acetylation, which thereby enhances c-Myc protein stability by inhibiting carboxyl terminus of heat shock cognate 70-kDa-interacting protein-mediated c-Myc ubiquitination and degradation. Importantly, TRAF6/HDAC3/c-Myc signaling is also primed in hepatitis B virus-transgenic mice, unveiling a critical role for a mechanism in inflammation-cancer transition. In clinical specimens, TRAF6 positively correlates with c-Myc at both the mRNA and protein levels, and high TRAF6 and c-Myc expression is associated with an unfavorable prognosis, suggesting that TRAF6 collaborates with c-Myc to promote human hepatocarcinogenesis. Consistently, curbing c-Myc expression by inhibition of TRAF6 activity with a TRAF6 inhibitor peptide or the silencing of c-Myc by small interfering RNA significantly suppressed tumor growth in mice. Conclusion: These findings demonstrate the oncogenic potential of TRAF6 during hepatocarcinogenesis by modulating TRAF6/HDAC3/c-Myc signaling, with potential implications for HCC therapy.
Subject(s)
Carcinogenesis , Carcinoma, Hepatocellular/genetics , Genes, myc/physiology , Histone Deacetylases/physiology , Liver Neoplasms/genetics , TNF Receptor-Associated Factor 6/physiology , Animals , Gene Expression Regulation, Neoplastic , Humans , Male , Mice , Protein Stability , Tumor Cells, CulturedABSTRACT
BACKGROUND: Type 2 diabetic kidney disease is the most common cause of chronic kidney diseases (CKD) and end-stage renal diseases (ESRD). Although kidney biopsy is considered as the 'gold standard' for diabetic kidney disease (DKD) diagnosis, it is an invasive procedure, and the diagnosis can be influenced by sampling bias and personal judgement. It is desirable to establish a non-invasive procedure that can complement kidney biopsy in diagnosis and tracking the DKD progress. METHODS: In this cross-sectional study, we collected 252 urine samples, including 134 uncomplicated diabetes, 65 DKD, 40 CKD without diabetes and 13 follow-up diabetic samples, and analyzed the urine proteomes with liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS). We built logistic regression models to distinguish uncomplicated diabetes, DKD and other CKDs. RESULTS: We quantified 559 ± 202 gene products (GPs) (Mean ± SD) on a single sample and 2946 GPs in total. Based on logistic regression models, DKD patients could be differentiated from the uncomplicated diabetic patients with 2 urinary proteins (AUC = 0.928), and the stage 3 (DKD3) and stage 4 (DKD4) DKD patients with 3 urinary proteins (AUC = 0.949). These results were validated in an independent dataset. Finally, a 4-protein classifier identified putative pre-DKD3 patients, who showed DKD3 proteomic features but were not diagnosed by clinical standards. Follow-up studies on 11 patients indicated that 2 putative pre-DKD patients have progressed to DKD3. CONCLUSIONS: Our study demonstrated the potential for urinary proteomics as a noninvasive method for DKD diagnosis and identifying high-risk patients for progression monitoring.
ABSTRACT
Protein-mediated RNA stabilization plays profound roles in chloroplast gene expression. Genetic studies have indicated that chloroplast ndhA transcripts, encoding a key subunit of the NADH dehydrogenase-like complex that mediates photosystem I cyclic electron transport and facilitates chlororespiration, are stabilized by PPR53 and its orthologs, but the underlying mechanisms are unclear. Here, we report that CHLOROPLAST RNA SPLICING 2 (CRS2)-ASSOCIATED FACTOR (CAF) proteins activate SUPPRESSOR OF THYLAKOID FORMATION 1 (SOT1), an ortholog of PPR53 in Arabidopsis thaliana, enhancing their affinity for the 5' ends of ndhA transcripts to stabilize these molecules while inhibiting the RNA endonuclease activity of the SOT1 C-terminal SMR domain. In addition, we established that SOT1 improves the splicing efficiency of ndhA by facilitating the association of CAF2 with the ndhA intron, which may be due to the SOT1-mediated stability of the ndhA transcripts. Our findings shed light on the importance of PPR protein interaction partners in moderating RNA metabolism.
Subject(s)
Arabidopsis Proteins/genetics , Arabidopsis Proteins/metabolism , Arabidopsis/growth & development , Chloroplasts/genetics , Arabidopsis/genetics , Arabidopsis/metabolism , Chloroplasts/metabolism , Gene Expression Profiling , Introns , NADH Dehydrogenase/genetics , RNA Splicing , RNA Splicing Factors/metabolism , RNA Stability , Sequence Analysis, RNAABSTRACT
Chloroplasts are plant organelles that carry out photosynthesis, produce various metabolites, and sense changes in the external environment. Given their endosymbiotic origin, chloroplasts have retained independent genomes and gene-expression machinery. Most genes from the prokaryotic ancestors of chloroplasts were transferred into the nucleus over the course of evolution. However, the importance of chloroplast gene expression in environmental stress responses have recently become more apparent. Here, we discuss the emerging roles of the distinct chloroplast gene expression processes in plant responses to environmental stresses. For example, the transcription and translation of psbA play an important role in high-light stress responses. A better understanding of the connection between chloroplast gene expression and environmental stress responses is crucial for breeding stress-tolerant crops better able to cope with the rapidly changing environment.
Subject(s)
Chloroplasts/genetics , Gene-Environment Interaction , Plants , Stress, Physiological/genetics , Adaptation, Physiological/genetics , Chloroplasts/metabolism , Environment , Gene Expression Regulation, Plant , Genes, Chloroplast/physiology , Genes, Plant/physiology , Plant Proteins/genetics , Plant Proteins/metabolism , Plants/genetics , Plants/metabolismABSTRACT
In the drug discovery process, unstable compounds in storage can lead to false positive or false negative bioassay conclusions. Prediction of the chemical stability of a compound by de novo methods is complex. Chemical instability prediction is commonly based on a model derived from empirical data. The COMDECOM (COMpound DECOMposition) project provides the empirical data for prediction of chemical stability. Models such as the extended-connectivity fingerprint and atom center fragments were built from the COMDECOM data and used for estimation of chemical stability, but deficits in the existing models remain. In this paper, we report DeepChemStable, a model employing an attention-based graph convolution network based on the COMDECOM data. The main advantage of this method is that DeepChemStable is an end-to-end model, which does not predefine structural fingerprint features, but instead, dynamically learns structural features and associates the features through the learning process of an attention-based graph convolution network. The previous ChemStable program relied on a rule-based method to reduce the false negatives. DeepChemStable, on the other hand, reduces the risk of false negatives without using a rule-based method. Because minimizing the rate of false negatives is a greater concern for instability prediction, this feature is a major improvement. This model achieves an AUC value of 84.7%, recall rate of 79.8%, and 10-fold stratified cross-validation accuracy of 79.1%.
Subject(s)
Cheminformatics/methods , Computer Graphics , Deep Learning , Drug Evaluation, Preclinical , Drug StabilityABSTRACT
Motivation: Small molecule drug candidates with attractive toxicity profiles that modulate target proteins through non-covalent interactions are usually favored by scientists and pharmaceutical industry. In the past decades, many non-covalent binding agents have been developed for different diseases. However, an increasing attention has been paid to covalent binding agents in pharmaceutical fields during recent years. Many covalent binding agents entered clinical trials and exerted significant advantages for diseases such as infection, cancers, gastrointestinal disorders, central nervous system or cardiovascular diseases. It has been recognized that covalent binding ligands can be attractive drug candidates. But, there is lack of resource to support covalent ligand discovery. Results: Hence, we initiated a covalent binder database (cBinderDB). To our best knowledge, it is the first online database that provides information on covalent binding compound structures, chemotypes, targets, covalent binding types and other biological properties. The covalent binding targets are annotated with biological functions, protein family and domains, gene information, modulators and receptor-ligand complex structure. The data in the database were collected from scientific publications by combining a text mining method and manual inspection processes. cBinderDB covers covalent binder's data up to September 2016. Availability and Implementation: cBinderDB is freely available at www.rcdd.org.cn/cbinderdb/. Contact: guqiong@mail.sysu.edu.cn or junxu@biochemomes.com . Supplementary information: Supplementary data are available at Bioinformatics online.
Subject(s)
Databases, Pharmaceutical , Data Mining , Drug Discovery , Ligands , Proteins/chemistry , Proteins/drug effects , Proteins/geneticsABSTRACT
BACKGROUND The aim of this study was to determine the clinical significance of the expression levels of bladder cancer-specific antigen-1 (BLCA-1) in the diagnosis of bladder cancer (BC). The study also determined the relationship between BLCA-1 expression levels and the clinical manifestation of BC. MATERIAL AND METHODS Patient samples were derived from 66 cases of BC that presented at the Department of Urology, Affiliated Hospital of Chengde Medical University, were recruited from April 2014 to May 2015, and 64 healthy control cases. Serum and urine BLCA-1 levels were detected by enzyme-linked immunosorbent assay (ELISA). RESULTS Urine BLCA-1 levels in BC patients were significantly higher than that found in healthy controls (P<0.01). BLCA-1 levels in the urine of patients without mucus membrane invasion (Ta) were significantly different from urine levels found in patients with mucus membrane invasion (T1-T4; P=0.022). BLCA-1 levels in the serum of patients without muscular coat invasion (Ta-T1) were significantly different than serum levels of patients with muscular coat invasion (T2-T4; P=0.042). CONCLUSIONS BLCA-1 is involved in the appearance and development of BC. Clinical detection of serum and urine BLCA-1 protein levels showed a high level of sensitivity and specificity in diagnosing BC. Further study of the functional expression of BLCA-1 levels as a valuable and novel diagnostic marker in BC is clearly warranted.
Subject(s)
Antigens, Neoplasm/blood , Antigens, Neoplasm/urine , Nuclear Matrix-Associated Proteins/blood , Nuclear Matrix-Associated Proteins/urine , Urinary Bladder Neoplasms/blood , Urinary Bladder Neoplasms/urine , Adult , Aged , Aged, 80 and over , Case-Control Studies , Female , Humans , Male , Middle Aged , ROC Curve , Sensitivity and Specificity , Urinary Bladder Neoplasms/diagnosis , Urinary Bladder Neoplasms/pathologyABSTRACT
BACKGROUND & AIMS: Aberrant estrogen receptor-α (ERα) expression and signaling are implicated in the development of hepatocellular carcinoma (HCC), but its regulation in HCC remains enigmatic. Herein, we aimed to identify a new mechanism by which ERα signaling is regulated in HCC, which may lead to a potential new strategy for HCC therapy. METHODS: Expression levels of Erbin and ERα in human HCC samples were evaluated by immunohistochemistry. In vitro and in vivo experiments were used to assess the effect of Erbin and ERα signaling on HCC cell growth. Crosstalk between Erbin and ERα signaling was analyzed by molecular methods. Animal models of diethylnitrosamine (DEN) or DEN/CCl4-induced HCC in wild-type Erbin+/+ and mutant ErbinΔC/ΔC mice were observed. The regulatory effects of Erbin on tamoxifen treatment of HCC were evaluated in vitro and in vivo. RESULTS: Erbin inactivated ERα signaling to drive tumorigenesis of HCC, acting to enhance binding of Chip to ERα via its interaction with ERα and thereby promoting ubiquitination and degradation of ERα. Deletion of the PDZ domain of Erbin in ErbinΔC/ΔC mice, disrupted the interaction of Chip and ERα, increased the stability of ERα protein, and thus inhibited tumorigenesis of HCC. Silencing of Erbin effectively sensitized the response of HCC after tamoxifen treatment in vitro and in vivo. CONCLUSIONS: Our data uncovered an important role of Erbin in regulating HCC tumorigenesis through inactivating ERα-mediated tumor-suppressive signaling, suggesting a new strategy for tamoxifen therapy in HCC by targeting Erbin/ERα signaling axis. LAY SUMMARY: Erbin expression is significantly elevated in human hepatocellular carcinoma (HCC) tissue. This elevated expression of Erbin contributes to tumorigenesis of HCC by negatively regulating ERα signaling. However, restoring ERα signaling by inhibiting Erbin expression enhances the sensitivity of HCC cells to tamoxifen treatment, providing a new approach for tamoxifen treatment in HCC.
Subject(s)
Adaptor Proteins, Signal Transducing/metabolism , Carcinoma, Hepatocellular/etiology , Carcinoma, Hepatocellular/metabolism , Estrogen Receptor alpha/metabolism , Liver Neoplasms/etiology , Liver Neoplasms/metabolism , Adaptor Proteins, Signal Transducing/antagonists & inhibitors , Adaptor Proteins, Signal Transducing/genetics , Animals , Antineoplastic Agents, Hormonal/therapeutic use , Carcinoma, Hepatocellular/drug therapy , Carrier Proteins/genetics , Carrier Proteins/metabolism , Cell Line, Tumor , Cell Proliferation , Estrogen Receptor alpha/genetics , Female , Gene Silencing , Humans , Immunohistochemistry , Intracellular Signaling Peptides and Proteins , Liver Neoplasms/drug therapy , Liver Neoplasms, Experimental/etiology , Liver Neoplasms, Experimental/genetics , Liver Neoplasms, Experimental/metabolism , Male , Mice , Mice, Inbred BALB C , Mice, Nude , Prognosis , Protein Stability , Sex Factors , Tamoxifen/therapeutic use , Ubiquitin-Protein Ligases/metabolism , Ubiquitination , Up-RegulationABSTRACT
Nur77, an immediate-early response gene, participates in a wide range of biological functions. Its human homologue, NUR77, is known by several names and has the HGNC-approved gene symbol NR4A1. However, the role of Nur77 in inflammatory bowel disease (IBD) and its underlying mechanisms remain elusive. Here, using public data from the International Inflammatory Bowel Disease Genetics Consortium (IIBDGC) on the most recent genome-wide association studies (GWAS) for ulcerative colitis (UC) and Crohn's disease (CD), we found that genetic variants of the NUR77 gene are associated with increased risk for both UC and CD. Accordingly, Nur77 expression was significantly reduced in colon tissues from patients with UC or CD and mice treated with DSS. Nur77 deficiency increased the susceptibility of mice to DSS-induced experimental colitis and prevented intestinal recovery, whereas treatment with cytosporone B (Csn-B), an agonist for Nur77, significantly attenuated excessive inflammatory response in the DSS-induced colitis mouse model. Mechanistically, NUR77 acts as a negative regulator of TLR-IL-1R signalling by interacting with TRAF6. This interaction prevented auto-ubiquitination and oligomerization of TRAF6 and subsequently inhibited NF-κB activation and pro-inflammatory cytokine production. Taken together, our GWAS-based analysis and in vitro and in vivo studies have demonstrated that Nur77 is an important regulator of TRAF6/TLR-IL-1R-initiated inflammatory signalling, and loss of Nur77 may contribute to the development of IBD, suggesting Nur77 as a potential target for the prevention and treatment of IBD.
Subject(s)
Colitis, Ulcerative/genetics , Crohn Disease/genetics , Nuclear Receptor Subfamily 4, Group A, Member 1/genetics , Receptors, Interleukin-1/metabolism , TNF Receptor-Associated Factor 6/metabolism , Toll-Like Receptors/metabolism , Adult , Aged , Animals , Colon/metabolism , Dextran Sulfate/pharmacology , Female , Genetic Predisposition to Disease , Genome-Wide Association Study , Humans , Male , Mice , Middle Aged , Nuclear Receptor Subfamily 4, Group A, Member 1/antagonists & inhibitors , Nuclear Receptor Subfamily 4, Group A, Member 1/deficiency , Phenylacetates/pharmacology , Prospective Studies , Signal Transduction/physiologyABSTRACT
To investigate the effects of aerobic exercise and starvation on growth performance, postprandial metabolic response and their interaction in a sedentary fish species, either satiation-fed or starved juvenile southern catfish (Silurus meridionalis) were exercised at 25 °C under three water velocities, i.e., nearly still water (control), 1 body length (bl) s(-1) and 2 bl s(-1), for eight weeks. Then, the feed intake (FI), food conversion efficiency (FCE), specific growth rate (SGR), morphological parameters, resting MO2 (MO2rest) and postprandial MO2 responses of the experimental fish were measured. Exercise at a low velocity (1 bl s(-1)) showed no effect on any growth performance parameter, whereas exercise at a high velocity (2 bl s(-1)) exhibited higher FI but similar SGR due to the extra energy expenditure from swimming and consequent decreased FCE. Starvation led to a significant body mass loss, whereas the effect intensified in both exercise groups. Exercise resulted in improved cardio-respiratory capacity, as indicated by increased gill and heart indexes, whereas it exhibited no effect on resting and postprandial metabolism in S. meridionalis. The starved fish displayed significantly larger heart, gill and digestive tract indexes compared with the feeding fish, suggesting selective maintenance of cardio-respiratory and digestive function in this fish species during starvation. However, starved fish still exhibited impaired digestive performance, as evidenced by the prolonged duration and low postprandial metabolic increase, and this effect was further exacerbated in both the 1 and 2 bl s(-1) exercise groups. These data suggest the following: (1) aerobic exercise produced no improvement in growth performance but may have led to the impairment of growth under insufficient food conditions; (2) the mass of different organs and tissues responded differently to aerobic exercise and starvation due to the different physiological roles they play; and (3) aerobic exercise had no effect on the postprandial metabolic response under a "normal feeding" situation, whereas it may have resulted in the impairment of the digestive capacity when food availability was low due to the competition of energy and oxygen under unfavorable conditions in juvenile S. meridionalis.
Subject(s)
Catfishes/physiology , Physical Conditioning, Animal/physiology , Postprandial Period/physiology , Starvation/physiopathology , Animals , Catfishes/metabolism , Digestion/physiology , Energy Metabolism/physiology , Gastrointestinal Tract/metabolism , Gastrointestinal Tract/pathology , Oxygen/metabolism , Oxygen Consumption , Starvation/metabolism , Swimming/physiologyABSTRACT
We investigated the effects of starvation and re-feeding on growth and swimming performance and their relationship in juvenile black carp (Mylopharyngodon piceus). We measured the specific growth rate (SGR), resting metabolic rate (RMR) and constant acceleration test speed (U CAT, the maximum swimming speed at exhaustion by constant acceleration test with 0.1667 cm s(-2) rate) in a treatment group (21 days of starvation then 21 days of re-feeding) and control group (routine feeding) (n = 20). Starvation resulted in a 17 % decrease in body mass of black carp (P < 0.05). After 21 days of re-feeding, body mass was greater than that of pre-starvation but still less than that of the control group at 42 days. During the re-feeding phase, the SGR of the treatment group was higher than that of the control group (P < 0.05). Starvation resulted in a significant decrease in the RMR and U CAT. After 21 days of re-feeding, both the RMR and U CAT recovered to the pre-starvation levels. In the control group, individual juvenile black carp displayed strong repeatability of the RMR and U CAT across the measurement periods (P ≤ 0.002). In the treatment group, RMR showed significant repeatability between pre-starvation and re-feeding (P = 0.007), but not between pre-starvation and starvation or between starvation and re-feeding. U CAT showed significant repeatability between pre-starvation and starvation (P = 0.006) and between pre-starvation and re-feeding (P = 0.001), but not between starvation and re-feeding. No correlation or only a weak correlation was found between any two variables of RMR, U CAT and SGR, whereas the increment of the U CAT (ΔU CAT) was negatively correlated with that of SGR during the starvation phase (r = -0.581, n = 20, P = 0.007) and re-feeding phase (r = -0.568, n = 20, P = 0.009). This suggested that within individual black carp, there is a trade-off between growth and maintenance (or development) of swimming performance under food-limited conditions.
Subject(s)
Carps , Starvation/physiopathology , Animals , Carps/growth & development , Carps/metabolism , Carps/physiology , Eating , Oxygen/metabolism , Starvation/metabolism , SwimmingABSTRACT
BACKGROUND: Segmentation of the magnetic resonance (MR) images is fundamentally important in medical image analysis. Intensity inhomogeneity due to the unknown noise and weak boundary makes it a difficult problem. METHOD: The paper presents a novel level set geodesic model which integrates the local and the global intensity information in the signed pressure force (SPF) function to suppress the intensity inhomogeneity and implement the segmentation. First, a new local and global region based SPF function is proposed to extract the local and global image information in order to ensure a flexible initialization of the object contours. Second, the global SPF is adaptively balanced by the weight calculated by using the local image contrast. Third, two-phase level set formulation is extended to a multi-phase formulation to successfully segment brain MR images. RESULTS: Experimental results on the synthetic images and MR images demonstrate that the proposed method is very robust and efficient. Compared with the related methods, our method is much more computationally efficient and much less sensitive to the initial contour. Furthermore, the validation on 18 T1-weighted brain MR images (International Brain Segmentation Repository) shows that our method can produce very promising results. CONCLUSIONS: A novel segmentation model by incorporating the local and global information into the original GAC model is proposed. The proposed model is suitable for the segmentation of the inhomogeneous MR images and allows flexible initialization.